Qingjie Ma

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy.

Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy.

Journal: Molecular pharmaceutics

Published: April 12, 2023

Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.

Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 22, 2022

Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.

Enzyme and Reactive Oxygen Species-Responsive Dual-Drug Delivery Nanocomplex for Tumor Chemo-Photodynamic Therapy.

Journal: International journal of nanomedicine

Published: October 18, 2022

Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer.

Hyaluronidase responsive second near-infrared fluorescent nanocomplex for combined HER2 blockade and chemotherapy of HER2+ breast cancer.

Journal: Biomaterials advances

Published: June 09, 2022

NIR-II Fluorescent Activatable Drug Delivery Nanoplatform for Cancer-Targeted Combined Photodynamic and Chemotherapy.

NIR-II Fluorescent Activatable Drug Delivery Nanoplatform for Cancer-Targeted Combined Photodynamic and Chemotherapy.

Journal: ACS applied bio materials

Published: January 19, 2022

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial.

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial.

Journal: JAMA oncology

Published: December 16, 2021

A novel association between Bmi-1 protein expression and the SUVmax obtained by 18F-FDG PET/CT in patients with gastric adenocarcinoma.

A novel association between Bmi-1 protein expression and the SUVmax obtained by 18F-FDG PET/CT in patients with gastric adenocarcinoma.

Journal: Open life sciences

Published: September 15, 2021

Correction to: Ultrathin gold nanowires to enhance radiation therapy.

Correction to: Ultrathin gold nanowires to enhance radiation therapy.

Journal: Journal of nanobiotechnology

Published: July 19, 2021

Bmi-1 directly upregulates glucose transporter 1 in human gastric adenocarcinoma.

Bmi-1 directly upregulates glucose transporter 1 in human gastric adenocarcinoma.

Journal: Open life sciences

Published: July 12, 2021

An Integrin-αvβ6/α5β1-Bitargeted Probe for the SPECT Imaging of Pancreatic Adenocarcinoma in Preclinical and Primary Clinical Studies.

An Integrin-αvβ6/α5β1-Bitargeted Probe for the SPECT Imaging of Pancreatic Adenocarcinoma in Preclinical and Primary Clinical Studies.

Journal: Bioconjugate chemistry

Published: June 17, 2021

Three-dimensional imaging for the localization of related anatomical structures during surgery on the internal auditory canal.

Three-dimensional imaging for the localization of related anatomical structures during surgery on the internal auditory canal.

Journal: BMC surgery

Published: June 16, 2021

First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer.

First-in-human pilot study of an integrin α6-targeted radiotracer for SPECT imaging of breast cancer.

Journal: Signal transduction and targeted therapy

Published: May 13, 2020

Showing 1-12 of 52

Last Updated: 09/26/2026